Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Merieux Developpement

Founders Francois Valencony

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 36
Average round size
info
The average size of a deal this fund participated in
$15M
Portfolio companies 27
Rounds per year 3.00
Lead investments 9
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Exits 10
Key employees 9
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Health Care
  • Biotechnology
  • Therapeutics
  • Manufacturing
  • Medical Device
Summary

Merieux Developpement is the famous VC, which was founded in 2009. The main office of represented VC is situated in the Lyon. The company was established in Europe in France.

The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. Deals in the range of 10 - 50 millions dollars are the general things for fund. The higher amount of exits for fund were in 2018. The real fund results show that this VC is 18 percentage points more often commits exit comparing to other companies. Opposing the other organizations, this Merieux Developpement works on 2 percentage points more the average amount of lead investments. The fund is constantly included in 2-6 deals per year.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Merieux Developpement, startups are often financed by Paladin Capital Group, Foresite Capital, NanoDimension. The meaningful sponsors for the fund in investment in the same round are NanoDimension, Shire, Paladin Capital Group. In the next rounds fund is usually obtained by Shire, Venrock, Paladin Capital Group.

The current fund was established by Francois Valencony. The overall number of key employees were 9.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 4 of the founder, the chance for it to get the investment is meager. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Pharmaceutical, Manufacturing. Among the most popular portfolio startups of the fund, we may highlight Origene Technologies, Amphivena Therapeutics, Inscripta, Inc.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Merieux Developpement:
Typical Co-investors
Merieux Developpement is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Merieux Developpement:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from France
Funds with similar focus located in France:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Angel Investment Fang Yonghua Investment -
Asia Plus Chicago, Illinois, United States
Aviva Ventures England, London, United Kingdom
Bank Muscat Masqat, Muscat, Oman
Bowman Capital California, San Mateo, United States
China Life APM Asset Management Beijing, Beijing, China
China Unicom Beijing, Beijing, China
Go-Ventures Indonesia, Jakarta, Jakarta Raya
Grey Sky Venture Partners Bellevue, United States, Washington
Huntington National Bank Columbus, Ohio, United States
IK Investment Partners England, London, United Kingdom
InnoCal Venture Capital California, Costa Mesa, United States
Loxbridge Research England, London, United Kingdom
NGC Ventures Central Region, Singapore, Singapore
Pablo Capital -
Pilot Wall Group Austin, Texas, United States
Shenzhen Qianhai Zhongyinhui Investment Management China, Guangdong, Shenzhen
Technicolor California, United States, West Hollywood
Up North -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

keepMED

Health Care
Health Diagnostics
Medical
$15M29 Sep 2020 North District

Amphivena Therapeutics

Biotechnology
Health Care
Therapeutics
$62M24 Sep 2019 South San Francisco, California, United States

Inscripta

Biotechnology
Health Care
Life Science
$20M04 Apr 2019 Boulder, Colorado, United States

Inscripta

Biotechnology
Health Care
Life Science
$30M19 Dec 2018 Boulder, Colorado, United States

Xeris Pharmaceuticals

Biotechnology
Diabetes
Health Care
Pharmaceutical
Therapeutics
$10M08 Mar 2018 Chicago, Illinois, United States

Inscripta

Biotechnology
Health Care
Life Science
$55M28 Feb 2018 Boulder, Colorado, United States

PhysioAssist

Health Care
Medical
Medical Device
$7M18 Sep 2017 Provence-Alpes-Côte d'Azur

Xeris Pharmaceuticals

Biotechnology
Diabetes
Health Care
Pharmaceutical
Therapeutics
$30M19 May 2017 Chicago, Illinois, United States

Health Care
Health Diagnostics
Medical Device
$25M09 Jan 2017 Irvine, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Merieux Developpement?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 36
Average round size 15M
Rounds per year 3.00
Peak activity year 2018
Lead investments 9
Follow on index 0.25
Exits 10
Group Appearance index 0.67

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

keepMED

Health Care
Health Diagnostics
Medical
$15M29 Sep 2020 North District

Amphivena Therapeutics

Biotechnology
Health Care
Therapeutics
$62M24 Sep 2019 South San Francisco, California, United States

Inscripta

Biotechnology
Health Care
Life Science
$20M04 Apr 2019 Boulder, Colorado, United States

Inscripta

Biotechnology
Health Care
Life Science
$30M19 Dec 2018 Boulder, Colorado, United States

Xeris Pharmaceuticals

Biotechnology
Diabetes
Health Care
Pharmaceutical
Therapeutics
$10M08 Mar 2018 Chicago, Illinois, United States

Inscripta

Biotechnology
Health Care
Life Science
$55M28 Feb 2018 Boulder, Colorado, United States

PhysioAssist

Health Care
Medical
Medical Device
$7M18 Sep 2017 Provence-Alpes-Côte d'Azur

Xeris Pharmaceuticals

Biotechnology
Diabetes
Health Care
Pharmaceutical
Therapeutics
$30M19 May 2017 Chicago, Illinois, United States

Health Care
Health Diagnostics
Medical Device
$25M09 Jan 2017 Irvine, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: